Applications & approvals
The FOPH is charged with regulating different areas of healthcare. In certain cases care providers, research establishments and other organisations are subject to notification or licensing requirements in connection with transplants, genetic analysis, controlled substances (narcotics), biosafety and research on embryonic stem cells. Find out here about how to proceed.
Access to official documents
When it comes to transparency, the administration in Switzerland leads by example. Find out here how to get access to official documents on the basis of the Freedom of Information Act (FoIA/BGö/LTrans).
Exceptional licences and licences for banned narcotics
The FOPH may grant exceptional licences for the handling of prohibited narcotics, licences in connection with diacetylmorphine-assisted treatment and licences for pilot trials with cannabis.
Applications and authorisations in the field of infectious diseases
Doctors and medical centres intending to administer yellow fever vaccinations need official authorisation from the FOPH. Here you’ll find everything you need to know to obtain a licence. You’ll also find information on how to apply for compensation in the event of a vaccine injury. The revised Epidemics Act that entered into force at the beginning of 2016 provides for financial compensation if certain requirements are met.
Applications and licences for stem cell research
Work involving human embryonic stem cells is subject to strict rules. Here researchers, ethics committees and medical personnel will find information on the relevant applications and licences.
Notifications and authorisations in the field of biosafety
The handling of genetically modified, pathogenic or alien organisms is subject to the notification or authorisation obligation. Here is information on the notification and authorisation procedures pursuant to the ContainO.